Ackman feels more pain on Valeant exit

摘要

The painful decline in the prospects and share price of valeant pharmaceuticals international has proved too much to bear for its most ardent supporter, billionaire hedge fund activist Bill Ackman. The sale late last Monday of Ackman's remaining stake in the debt-laden drugmaker closed the door on one of the worst single stock investment losses in recent times - and it also came with a sting in the tail.